Centogene N.V.

In News

Net current asset value per share of Centogene NV – MUN:39K - TradingView

TradingView - Apr 01, 2026

Centogene NV (HAM:39K) PB Ratio : (As of Mar. 27, 2026) - GuruFocus

GuruFocus - Mar 27, 2026

CENTOGENE Finalizes Private Equity Buyout: What Shareholders Need for Liquidation Payout - Stock Titan

Stock Titan - Mar 12, 2025

Centogene Launches Whole Genome Sequencing Solution for Rare Disease Diagnosis - Clinical Lab Products

Clinical Lab Products - Apr 12, 2023

Centogene and Lifera kick-off joint venture - European Biotechnology Magazine

European Biotechnology Magazine - Jun 27, 2023

Centogene and Evotec announce discovery of small molecule to treat Gaucher disease - BioWorld MedTech

BioWorld MedTech - May 15, 2024

Lifera and CENTOGENE enter into a strategic collaboration - World Business Outlook

World Business Outlook - Jul 02, 2024

Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics - Business Wire

Business Wire - Jan 10, 2023

Centogene N.v. Stock Price Forecast. Should You Buy CNTG? - StockInvest.us

StockInvest.us - Dec 02, 2020

Centogene N.V. Appoints Prof. Peter Bauer, Chief Medical and Genomic Officer to its Management Board and as Managing Director of the subsidiary Centogene GmbH - MarketScreener

MarketScreener - Jan 30, 2023

Premier Research and CENTOGENE Launch Strategic Partnership to Accelerate and De-Risk Rare Disease Clinical Development - PR Newswire

PR Newswire - Jan 09, 2023

CENTOGENE Sells Operating Assets for €8.7M to Charme Capital, Plans Liquidation - Stock Titan

Stock Titan - Nov 13, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment